High dose intravenous immunoglobin for systemic lupus erythematosus with lupus nephritis and associated studies - case report
- Author:
Lim SK
;
Tan SY
- Publication Type:Journal Article
- Keywords:
Systemic lupus erythematosus, lupus nephritis, Intravenous Immunoglobulin
- From:Journal of University of Malaya Medical Centre
2007;10(2):51-56
- CountryMalaysia
- Language:English
-
Abstract:
Systemic lupus erythematosus (SLE) is one of the commonest systemic autoimmune
diseases that can present with variable clinical manifestations. Intravenous Immunoglobulin (IVIG)
has been used as a salvage therapy for severe lupus with encouraging results though there is yet
randomised trial to support the usage. This report highlights the efficacy and safety of high dose IVIG
in SLE patients with multi-organ involvement particularly lupus nephritis. We also reviewed the
literature on the usage of IVIG for lupus nephritis. However, more studies are needed to further clarify
the optimal therapeutic dosage and regime for IVIG and to identify the group of patients who might
benefit the most from this expensive therapy.